SG biotech firm Austrianova secures $100m commitment from GEM

SG biotech firm Austrianova secures $100m commitment from GEM

Photo: Austrianova

Biotech company Austrianova has signed an agreement with Luxembourg-based private equity firm GEM Global Yield for a share subscription facility of up to $100 million for a 36-month term following a public listing.

The agreement allows Austrianova to draw down funds by issuing shares of common stock to GEM, the company said in a statement. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter